Arrayed screening
Using synthetic CRISPR and siRNA reagents on a one-gene per well basis with complex assay readouts.
Functional genomic screens enable modulation of hundreds or thousands of genes in a single experiment to identify genetic pathways, cellular processes, novel therapeutic targets, and to genetically profile existing or potential therapeutics. This information can be used to support cell line development, elucidate mechanisms of action, facilitate patient stratification or explore new treatment paradigms.
With integrated solutions for CRISPR knockout, CRISPR activation, CRISPR inhibition, and RNAi technologies our screening portfolio provides you a complete functional genomic screening platform. Using either cell lines or primary cell cultures, Horizon’s screening platform can perform pooled, arrayed and even single cell screens with our flexible library technologies and formats. Libraries can be used either alone, or in tandem, and coupled with a variety of assay readouts.
Pooled screening
Employing lentiviral CRISPRko/i/a approaches in highly multiplexed pooled screens.
CRISPR knockout screening services
Probe gene function. Find drug targets. Stratify patients.
Ensuring library specificity with algorithm optimized guide RNA.
Custom services available for unique research projects.
Custom services available for unique research projects.
siRNA screening services
Benefit from rapid and efficient workflows.
Building on Dharmacon's 20+ years as the world leader in siRNA development, design and synthesis.
RNA-based immune cell screens
Screening services for primary human immune cells.
Address clinically relevant biological questions in vitro.
Screening libraries
Flexibility to scale to your needs
Select from whole genome or gene family catalog CRISPR and RNAi libraries or create a custom library in pooled or arrayed format.
Gene modulation technologies in the development of cell based therapies
Learn about the principles, strategies and experimental outcomes of CRISPR screening
App note: Pooled phenotypic CRISPR screens
Read more about pooled CRISPR–Cas9 knock-out screens - valuable tools for new drug target identification
App note: Dual CRISPRi/a screens
Read about CRISPR screens for:
- Drug mechanisms of action
- Target identification and validation
CRISPRa screening
CRISPR activation offers transient gain-of-function screening using endogenous expression mechanisms.
CRISPRi screening
CRISPR interference screening offers transient loss-of-function screening with the accuracy of the CRISPR guide system.
Dual CRISPRi/a screening
Exploit the power of paired loss-of-function and gain-of-function screening.
Use of parallel CRISPRi and CRISPRa gene modulation to identify drug interactions with paired gene perturbation analysis.
App note: Whole-genome CRISPRa screening
In this application note, we present a human whole-genome CRISPRa platform and demonstrate its effectiveness in identifying resistance genes complementary to those identified through loss-of-function screening. The ability to enhance transcription by several orders of magnitude offers researchers the opportunity to explore resistance mechanisms based on a CRISPRa-driven gain-of-function platform.
Single-cell CRISPR screening
Identify the genetic interactions that underlie a treatment response with pooled CRISPR screening followed by single cell analysis.
Functional genomic screening with CRISPR technologies
Learn about CRISPR screening and techniques
Review article
Read a recent insightful review article headlining in SLAS Discovery's March issue entitled 'CRISPR: A Screener's Guide'.
CRISPR screens in primary human T cells
Gain a better understanding of how immune cells function using functional genomic screens.
Podcast: CRISPR screens
Listen to the recent podcast hosted by GEN:
CRISPR Screens Speed Drug Discovery Efforts in Disease Intervention